Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neal Shore

Showing results (1-10 of 191) with videos related to

Pageof 20
Sort By:
The American Journal of Managed Care|March 4, 2015
Management of early-stage prostate cancerNeal Shore
Clinical Advances in Hematology & Oncology : H&O|January 17, 2025
Incorporating PSMA PET imaging into the treatment plan for newly diagnosed and recurrent prostate cancerNeal Shore
Urology|March 13, 2026
Editorial Comment on "Homologous recombination repair mutations, next-generation sequencing testing, and treatment progression by race among patients with metastatic castration-sensitive prostate cancer"Neal Shore
Expert Opinion on Investigational Drugs|January 7, 2010
NX-1207: a novel investigational drug for the treatment of benign prostatic hyperplasiaNeal Shore
The Journal of Urology|February 10, 2025
Reply: Clinician-Reported Management Recommendations in Response to Universal Germline Genetic Testing in Patients With Prostate CancerNeal Shore
Current Bladder Dysfunction Reports|May 19, 2015
A Review of the Prostatic Urethral Lift for Lower Urinary Tract Symptoms: Symptom Relief, Flow Improvement, and Preservation of Sexual Function in Men With Benign Prostatic HyperplasiaNeal Shore
Current Urology Reports|May 13, 2014
Management of advanced prostate cancer - role of the urologistNeal Shore
Therapeutic Advances in Chronic Disease|December 20, 2012
The potential for NX-1207 in benign prostatic hyperplasia: an update for cliniciansNeal Shore, Barrett Cowan
European Urology|October 23, 2025
Reply to Xianghu Meng, Yibo Hua, and Rijin Song's Letter to the Editor re: Stephen J. Freedland, John P. Mulhall, Martin Gleave, et al. Effects of Enzalutamide on the Sexual Activity of Patients with Biochemically Recurrent Prostate Cancer: A Post Hoc Analysis of Patient-reported Outcomes in the EMBARK Study. Eur Urol 2025;87:507-11Stephen J Freedland, Neal Shore
Urology|June 26, 2019
AUTHOR REPLYJeremy B Shelton, Neal Shore
Pageof 20

Showing results (1-10 of 191) with videos related to

Sort By:
Pageof 20
The American Journal of Managed Care|March 4, 2015
Management of early-stage prostate cancerNeal Shore
Clinical Advances in Hematology & Oncology : H&O|January 17, 2025
Incorporating PSMA PET imaging into the treatment plan for newly diagnosed and recurrent prostate cancerNeal Shore
Urology|March 13, 2026
Editorial Comment on "Homologous recombination repair mutations, next-generation sequencing testing, and treatment progression by race among patients with metastatic castration-sensitive prostate cancer"Neal Shore
Expert Opinion on Investigational Drugs|January 7, 2010
NX-1207: a novel investigational drug for the treatment of benign prostatic hyperplasiaNeal Shore
The Journal of Urology|February 10, 2025
Reply: Clinician-Reported Management Recommendations in Response to Universal Germline Genetic Testing in Patients With Prostate CancerNeal Shore
Current Bladder Dysfunction Reports|May 19, 2015
A Review of the Prostatic Urethral Lift for Lower Urinary Tract Symptoms: Symptom Relief, Flow Improvement, and Preservation of Sexual Function in Men With Benign Prostatic HyperplasiaNeal Shore
Current Urology Reports|May 13, 2014
Management of advanced prostate cancer - role of the urologistNeal Shore
Therapeutic Advances in Chronic Disease|December 20, 2012
The potential for NX-1207 in benign prostatic hyperplasia: an update for cliniciansNeal Shore, Barrett Cowan
European Urology|October 23, 2025
Reply to Xianghu Meng, Yibo Hua, and Rijin Song's Letter to the Editor re: Stephen J. Freedland, John P. Mulhall, Martin Gleave, et al. Effects of Enzalutamide on the Sexual Activity of Patients with Biochemically Recurrent Prostate Cancer: A Post Hoc Analysis of Patient-reported Outcomes in the EMBARK Study. Eur Urol 2025;87:507-11Stephen J Freedland, Neal Shore
Urology|June 26, 2019
AUTHOR REPLYJeremy B Shelton, Neal Shore
Pageof 20